Costs and benefits of cervical screening .3. Cost/benefit analysis of a call of previously unscreened women

被引:4
|
作者
Waugh, N
Smith, I
Robertson, A
Reid, GS
Halkerston, R
Grant, A
机构
[1] UNIV DUNDEE,DEPT PATHOL,DUNDEE DD1 4HN,SCOTLAND
[2] TAYSIDE HLTH BOARD,DUNDEE,SCOTLAND
[3] PERTH ROYAL INFIRM LABS,PERTH,SCOTLAND
[4] TAYSIDE HLTH BOARD,DEPT FINANCE,PERTH & KINROSS UNIT,PERTH,SCOTLAND
关键词
cervical screening; call; economics; costs;
D O I
10.1046/j.1365-2303.1996.40182401.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
A population-based cervical screening programme issued invitations to women with no record of a previous smear. This call was very good value, at pound 5780 per life saved or pound 159 per life-year saved at 1991 prices. The first priority for the cervical screening service should be comprehensive coverage.
引用
收藏
页码:249 / 255
页数:7
相关论文
共 50 条
  • [1] The costs and benefits of cost-benefit analysis
    Wolfson, A
    [J]. PUBLIC INTEREST, 2001, (145) : 93 - 99
  • [2] Costs and benefits of cervical screening IV: valuation by women of the cervical screening programme
    Wordsworth, S
    Ryan, M
    Waugh, N
    [J]. CYTOPATHOLOGY, 2001, 12 (06) : 367 - 376
  • [4] Some Costs & Benefits of Cost-Benefit Analysis
    Sunstein, Cass R.
    [J]. DAEDALUS, 2021, 150 (03) : 208 - 219
  • [5] The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women
    Goldie, SJ
    Weinstein, MC
    Kuntz, KM
    Freedberg, KA
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 130 (02) : 97 - +
  • [6] Accounting for the Distribution of Benefits and Costs in Benefit-Cost Analysis
    Hammitt, James K.
    [J]. JOURNAL OF BENEFIT-COST ANALYSIS, 2021, 12 (01) : 64 - 84
  • [7] Cost benefit analysis of the Cervical Cancer Screening Program.
    HernandezPena, P
    LazcanoPonce, EC
    AlonsodeRuiz, P
    CruzValdez, A
    MenesesGonzalez, F
    HernandezAvila, M
    [J]. SALUD PUBLICA DE MEXICO, 1997, 39 (04): : 379 - 387
  • [8] The balance of harms, benefits, and costs of screening for cervical cancer in older women - The case for continued screening
    Mandelblatt, J
    Lawrence, W
    Yi, B
    King, J
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (03) : 245 - 247
  • [9] COST-BENEFIT ANALYSIS OF POPULATION SCREENING BY MEANS OF CERVICAL SMEARS
    WOLFENDALE, M
    [J]. ACTA CYTOLOGICA, 1974, 18 (05) : 438 - 439
  • [10] Marginal costs of extragenital screening by Aptima Combo 2 in women - a cost benefit assessment
    Ahmad, S.
    Jewsbury, S.
    [J]. HIV MEDICINE, 2014, 15 : 90 - 90